N-Acetylcysteine and Other Preventive Measures for Contrast-Induced Nephropathy in the Intensive Care Unit

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|21|2565-2570

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.21, 2006-09, pp. : 2565-2570

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stability of a Formulated N‐acetylcysteine Capsule for Prevention of Contrast‐Induced Nephropathy

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 219-222

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of contrast-induced nephropathy

By  

Reactions Weekly, Vol. 1, Iss. 1370, 2011-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Fenoldopam does not prevent contrast-induced nephropathy

By  

Inpharma, Vol. 1, Iss. 1413, 2003-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Assessment of Urinary N-Acetyl-β-glucosaminidase as an Early Marker of Contrast-induced Nephropathy

By Ren L   Ji J   Fang Y   Jiang SH   Lin YM   Bo J   Qian JY   Xu XH   Ding XQ  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 647-653

Field House Publishing

Access to resources Recommend Favorite

Radiocontrast-induced nephropathy and percutaneous coronary intervention: a review of preventive measures

By Mintz Edward P   Gruberg Luis  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 639-652

Informa Healthcare

Access to resources Recommend Favorite